DBV Technologies (DBVT) Invested Capital (2015 - 2020)
DBV Technologies (DBVT) posted quarterly Invested Capital of $665703.2 for Q2 2020, up 2.27% year-on-year from $650909.8 in Q3 2019, and down 99.14% on a QoQ basis from $77.1 million in Q4 2019.
DBV Technologies (DBVT) Invested Capital (2015 - 2020) Analysis & Trends
DBV Technologies (DBVT) has reported Invested Capital for 6 consecutive years, with $665703.2 the latest figure, recorded in Q2 2020.
- Quarterly Invested Capital rose 2.27% year-over-year to $665703.2 in Q2 2020, while the trailing twelve-month figure through Mar 2021 was $665703.2 (down 99.5% YoY) and the FY2019 annual result came in at $77.1 million, up 42.26% from the prior year.
- Invested Capital eased to $665703.2 in Q2 2020 per DBVT's latest filing, from $77.1 million in the prior quarter.
- Over the last five years, Invested Capital for DBVT reached as high as $77.1 million in Q4 2019 and fell as low as $650909.8 in Q2 2019.
- A 5-year average of $33.3 million and a median of $27.5 million in 2018 frame the typical range for Invested Capital.
- Annual changes were most pronounced in 2017 — Invested Capital jumped 7634.52% — and 2018, when it declined 17.8%.
- Year by year, Invested Capital stood at $852936.9 in 2016, then soared by 7634.52% to $66.0 million in 2017, then slipped by 17.8% to $54.2 million in 2018, then surged by 42.26% to $77.1 million in 2019, then slumped by 99.14% to $665703.2 in 2020.
- According to Business Quant data, Invested Capital over the past three periods registered $665703.2, $77.1 million, and $650909.8 for Q2 2020, Q4 2019, and Q2 2019 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 116.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 665,703.25 |
| Dec 31, 2019 | 77.15 Mn |
| Jun 30, 2019 | 650,909.84 |
| Dec 31, 2018 | 54.23 Mn |
| Dec 31, 2017 | 65.97 Mn |
| Dec 31, 2016 | 852,936.93 |
| Dec 31, 2015 | 215,038.24 |